Pharmaniaga Berhad operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pharmaniaga Berhad with three other
drug stores in Asia:
Cachet Pharmaceutical Company., Limited
sales of 3.54 billion Chinese Renmimbi [US$571.10 million]
of which 99%
Jiangsu Nhwa Pharmaceutical Company Limited
(2.24 billion Chinese Renmimbi [US$360.42 million]
of which 51%
was Medicine Commerce), and
Harima-Kyowa Company Limited
based in Japan
(36.57 billion Japanese Yen [US$360.56 million]
of which 85%
was Wholesale Business).
During the year ended December of 2013, sales at
Pharmaniaga Berhad were 1.95 billion Malaysian Ringgits (US$613.11 million).
increase of 7.4%
versus 2012, when the company's sales were 1.81 billion Malaysian Ringgits.
This was the fourth straight year of sales growth at Pharmaniaga Berhad.
Sales of Logistics and Distribution saw an increase
9.5% in 2013, from
1.78 billion Malaysian Ringgits to 1.95 billion Malaysian Ringgits.
Not all segments of Pharmaniaga Berhad experienced an increase in sales in 2013:
sales of Manufacturing fell 98.1% to 690,000.00 Malaysian Ringgits.
(However, this segment's sales were only a very small portion of the company's overall sales).